Next Article in Journal
Individual Treatment Trials—Do Experts Know and Use This Option to Improve the Treatability of Mucopolysaccharidosis?
Next Article in Special Issue
Antibody–Drug Conjugates for Multiple Myeloma: Just the Beginning, or the Beginning of the End?
Previous Article in Journal
Clinical Impact of Electronic Monitoring Devices of Inhalers in Adults with Asthma or COPD: A Systematic Review and Meta-Analysis
Previous Article in Special Issue
Review on Bortezomib Resistance in Multiple Myeloma and Potential Role of Emerging Technologies
 
 
Review

Article Versions Notes

Pharmaceuticals 2023, 16(3), 415; https://doi.org/10.3390/ph16030415
Action Date Notes Link
article xml file uploaded 8 March 2023 18:06 CET Original file -
article xml uploaded. 8 March 2023 18:06 CET Update -
article pdf uploaded. 8 March 2023 18:06 CET Version of Record https://www.mdpi.com/1424-8247/16/3/415/pdf-vor
article html file updated 8 March 2023 18:07 CET Original file -
article html file updated 20 March 2023 21:50 CET Update -
article xml file uploaded 23 March 2023 11:09 CET Update -
article xml uploaded. 23 March 2023 11:09 CET Update https://www.mdpi.com/1424-8247/16/3/415/xml
article pdf uploaded. 23 March 2023 11:09 CET Updated version of record https://www.mdpi.com/1424-8247/16/3/415/pdf
article html file updated 23 March 2023 11:11 CET Update https://www.mdpi.com/1424-8247/16/3/415/html
Back to TopTop